Paushak Limited

Paushak Limited

621.05
INR
-34.20
(-5.22%)
17.19EPS
28.91P/E
12.25BMarket Cap
Paushak Limited
NSE:PAUSHAKLTD
(National Stock Exchange of India)

Recent

price

621.05

P/E

ratio

28.91

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
11.4
12.75
18.96
21.06
26.89
30.36
25.66
39.59
55.27
55.24
56.59
60.23
85.48
83.08
84.98
88.04
99.87
Revenue per Share
1.44
1.34
3.04
3.44
5.06
4.84
4.26
8.37
15.71
14.16
15.13
15.25
21.9
22.04
20.03
15.95
17.19
Basic EPS, GAAP
0.14
-0.26
0.69
2.09
0.1
-1.18
2.68
1.89
5.31
9.83
-10.53
-1.73
10.37
6.87
-49.83
-13.97
- -
Free Cash Flow per Basic Share
0.23
0.23
0.23
0.35
0.35
0.35
0.37
0.37
0.37
0.62
0.75
0.75
1.49
2.16
2.45
2.45
- -
Dividend per Share
89.17
97.59
118.39
142.41
178.96
231.7
258.86
352.75
576.12
737.29
881.42
991.4
1,147.57
1,324.17
1,510.29
199.18
- -
Book Value per Share
89.17
97.59
118.39
142.41
178.96
231.7
258.86
352.75
576.02
737.06
880.82
990.98
1,147.28
1,324.01
1,510.12
199.17
- -
Tangible Book Value per Share
26
26
26
26
26
26
26
26
25
25
25
25
25
25
25
25
25
Basic Weighted Avg Shares
292
327
486
540
690
779
658
1,016
1,371
1,362
1,395
1,485
2,108
2,048
2,095
2,171
2,463
Sales/Revenue/Turnover
14.87
6.17
20.39
20.47
24.63
19.26
13.95
25.95
26.6
28.23
32.66
30.54
29.35
25.2
21.71
18.44
17.41
Operating Margin (%)
16
17
18
18
21
28
32
34
39
44
50
90
134
138
150
214
257
Depreciation Expense
37
34
78
88
130
124
109
215
390
349
373
376
540
544
494
393
424
Net Income, GAAP
23.41
16.52
27.37
30.1
27.76
25.24
22.49
25.62
20.48
23.06
27.7
25.19
25.22
23.44
15.99
21.99
21.21
Effective Tax Rate (%)
12.65
10.54
16.03
16.32
18.84
15.94
16.62
21.14
28.41
25.63
26.73
25.32
25.62
26.53
23.57
18.11
17.21
Profit Margin (%)
51
73
163
251
289
299
191
334
751
943
677
765
1,249
1,896
551
662
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
250
600
- -
LT Debt
286
313
380
457
574
743
830
1,131
1,776
2,272
2,717
3,056
3,537
4,081
4,655
4,911
- -
Total Equity
12.57
10.52
21.09
20.56
24.91
16.81
8.96
19.73
24.98
15.41
13.21
11.69
14.33
10.3
8.45
5.82
- -
Return on Invested Capital (%)
13.72
11.34
21.58
20.93
25.16
18.76
13.88
21.83
26.75
17.25
14.95
13.04
16.44
14.29
11.01
7.59
- -
Return on Capital (%)
13.65
11.51
22.51
21.09
25.21
18.86
13.91
21.89
26.8
17.25
14.95
13.03
16.38
14.27
11.3
8.22
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
169
- -
LT Borrowings
- -
600
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
25
25
Market Capitalization
14,663
8,504
12,253

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,317
- -
Cash, Cash Equivalents & STI
- -
274
- -
Accounts Receivable, Net
- -
549
- -
Inventories
- -
366
- -
Total Current Liabilities
- -
654
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
169
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.57%
12.64%
5.51%
Free Cash Flow
-202.08%
-342.7%
-71.97%
Net Income, GAAP
17.78%
3.11%
-20.36%
Sales/Revenue/Turnover
12.7%
10.29%
3.61%
Total Cash Common Dividend
24.55%
31.46%
-0.02%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
520
573
493
524
2,095
2026
559
588
488
551
2,171
2027
836
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4.18
5.76
6.19
3.9
20.03
2026
4.88
3.49
2.5
5.07
15.95
2027
6.13
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
2.45
2026
- -
- -
- -
- -
2.45
2027
- -
- -
- -
- -
- -
Business
Paushak Limited is a specialty chemicals company primarily engaged in the production of phosgene gas and phosgene-based specialty chemicals and intermediates, including isocyanates, chloroformates, and chlorides. It also offers contract development and manufacturing organization (CDMO) services, advanced research and development capabilities for proprietary molecules, and engineering and design services. The company serves pharmaceutical, agrochemical, and other industrial sectors with multipurpose plants capable of handling complex manufacturing requirements at various scales. It operates globally with a strong focus on safe, sustainable, and reliable phosgene chemistry and supply security. Founded in 1968 and headquartered in India, Paushak is recognized as the largest phosgene-based specialty chemical producer in India. Recent major developments include a strategic expansion approved by Indian authorities to triple its phosgene production capacity from 4,800 metric tons to 14,400 metric tons, funded through internal accruals, aimed at achieving economies of scale and enhancing cost competitiveness globally. Paushak has launched innovative products such as the patented, CIB-approved agricultural yield enhancer "Paushak Super Star," developed with advanced research collaborations to improve crop growth and soil health. The company has also announced a stock split and bonus issue in 2025 to enhance liquidity. Paushak continues to pursue import substitution by developing indigenous technology for key specialty chemicals, reinforcing its position in the domestic and international markets. It is part of a group structure involving Alembic Limited and related entities, focusing on vertical integration and simplification of operations.